Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 January 2024 | Story Leonie Bolleurs | Photo Supplied
Prof Gert van Zyl
The Dean of the Faculty of Health Sciences, Prof Gert van Zyl, was recently appointed as the Chairperson of the South African Committee of Medical Deans (SACOMD).

The Dean of the Faculty of Health Sciences at the University of the Free State (UFS), Prof Gert van Zyl, was appointed as the Chairperson of the South African Committee of Medical Deans (SACOMD).

Prof Van Zyl, who has been a member of the SA Committee of Medical Deans since 2001, says it is a privilege and a highlight to again serve the health sciences academic community in this very dynamic and special time for medical schools.

He is especially looking forward to working with a brilliant team of deans and leaders in SACOMD, to build on the achievements of the past, and to excel in those areas that they have collectively decided to pursue for the future.

Taking on the role of Chairperson of SACOMD once more, leading with an outstanding team and a shared vision, signifies a special moment in his career, particularly as he approaches the conclusion of a fulfilling journey as dean. During his tenure, Prof Van Zyl was dedicated to actively contributing to stakeholders in the health sciences arena, including the academic community, SACOMD, as well as staff and students at the university.

He is of the opinion that this position brings exceptional value to both the faculty and the university. “It aligns with their collective vision of academic excellence across undergraduate and postgraduate teaching and learning as well as research,” he states.

SACOMD’s strategy for 2024

The Committee’s goal is to facilitate the optimisation and transformation of academic activities in Health Sciences faculties in order to meet the healthcare, research, and social imperatives of the country.

During a strategic session held in 2023, SACOMD determined the following objectives that align with their goal. According to Prof Van Zyl, they will strive to embrace collaboration, establish trust-based relationships among its members, seek proactive and consensus-driven decision-making, share information (drawing knowledge and insights from each other) to collectively advance thought leadership, and leverage their position as an influencer for improved health sciences training and strengthened health systems.

He says there are some exciting trends in a number of areas that will play an important role in advancing medical and health sciences. This includes the role of artificial intelligence, simulation, and robotic surgery in the academic health sciences arena.

As a committee, they will also look at the establishment of work-based assessment as a requirement in the postgraduate training environment of medical specialists in South Africa, the role of higher education academia in a National Health Insurance (NHI) system, as well as improving undergraduate and postgraduate teaching and learning. “All these activities are already guided by a set of detailed actions, responsibility areas, and academic outcomes,” he says.

Furthermore, they will provide support for new medical schools in order to serve the country in producing excellent health professionals. In doing so, they plan to create a more sustainable funding environment, improve the world-class status of training in both undergraduate and postgraduate teaching, and influence important clinical training platforms to support the academic health sciences agenda.

Patients is our first priority

Although operating on a strategic level in serving the health sciences community, Prof Van Zyl also shares his thoughts with students who aspire to pursue a career in this field. “Choose a career for the right reasons. Do not forget that your patients are your first priority in everything you do. Make the most of the opportunity if you are in the privileged position to be selected to study and build a career in health sciences,” he says.

He adds that resilience is an important characteristic when deciding to pursue a career in the medical field. According to him, it is also key to be a team player, have sound mental and spiritual health, and to have compassion in everything you do as a health sciences professional.

“Play this role as a team member, with the oath you have taken and with the Declaration of Geneva’s emphasis on the welfare of patients as your compass. Live this out in your daily professional activities. You are part of a group of professionals known for healing and caring for communities. Play the role required.”

“Mother Theresa said, ‘I alone cannot change the world, but I can cast a stone across the waters to create many ripples.’” “Create your own ripples!” Prof Van Zyl urges aspiring medical professionals.

News Archive

Carbon dioxide makes for more aromatic decaffeinated coffee
2017-10-27


 Description: Carbon dioxide makes for more aromatic decaffeinated coffee 1b Tags: Carbon dioxide makes for more aromatic decaffeinated coffee 1b 

The Inorganic Group in the Department of Chemistry
at the UFS is systematically researching the utilisation
of carbon dioxide. From the left, are, Dr Ebrahiem Botha,
Postdoctoral Fellow; Mahlomolo Khasemene, MSc student;
Prof André Roodt; Dr Marietjie Schutte-Smith, Senior Lecturer;
and Mokete Motente, MSc student.
Photo: Charl Devenish

Several industries in South Africa are currently producing hundreds of thousands of tons of carbon dioxide a year, which are released directly into the air. A typical family sedan doing around 10 000 km per year, is annually releasing more than one ton of carbon dioxide into the atmosphere.

The Inorganic Chemistry Research Group in the Department of Chemistry at the University of the Free State (UFS), in collaboration with the University of Zurich in Switzerland, has focused in recent years on using carbon dioxide – which is regarded as a harmful and global warming gas – in a meaningful way. 

According to Prof André Roodt, Head of Inorganic Chemistry at the UFS, the Department of Chemistry has for the past five decades been researching natural products that could be extracted from plants. These products are manufactured by plants through photosynthesis, in other words the utilisation of sunlight and carbon dioxide, nitrogen, and other nutrients from the soil.

Caffeine and chlorophyll 
“The Inorganic group is systematically researching the utilisation of carbon dioxide. Carbon dioxide is absorbed by plants through chlorophyll and used to make interesting and valuable compounds and sugars, which in turn could be used for the production of important new medicines,” says Prof Roodt.

Caffeine, a major energy enhancer, is also manufactured through photosynthesis in plants. It is commonly found in tea and coffee, but also (artificially added) in energy drinks. Because caffeine is a stimulant of the central nervous system and reduces fatigue and drowsiness, some people prefer decaffeinated coffee when enjoying this hot drink late at night. 

Removing caffeine from coffee could be expensive and time-consuming, but also environmentally unfriendly, because it involves the use of harmful and flammable liquids. Some of the Inorganic Group’s research focus areas include the use of carbon dioxide for the extraction of compounds, such as caffeine from plants. 

“Therefore, the research could lead to the availability of more decaffeinated coffee products. Although decaffeinated coffee is currently aromatic, we want to investigate further to ensure better quality flavours,” says Prof Roodt.

Another research aspect the team is focusing on is the use of carbon dioxide to extract chlorophyll from plants which have medicinal properties themselves. Chemical suppliers sell chlorophyll at R3 000 a gram. “In the process of investigating chlorophyll, our group discovered simpler techniques to comfortably extract larger quantities from green vegetables and other plants,” says Prof Roodt.

Medicines
In addition, the Inorganic Research Group is also looking to use carbon dioxide as a building block for more valuable compounds. Some of these compounds will be used in the Inorganic Group’s research focus on radiopharmaceutical products for the identification and possibly even the treatment of diseases such as certain cancers, tuberculosis, and malaria.

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept